1971515
Last Update Posted: 2018-09-19
Recruiting has ended
All Genders accepted | 18 Years + |
101 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies
This is a Phase 1, first-in-human, open-label, non-randomized, dose escalation, trial to explore the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical activity signals of MSC2363318A.
Eligibility
Relevant conditions:
Solid Tumor
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov